EPTMF (Epitomee Medical) EBITDA Margin %: -1,770.89% (As of Dec. 2025)


EPTMF Epitomee Medical Ltd EPTMF
29 GF Score
Price $0.99
! 3 Warning Signs
View Full Analysis

What is Epitomee Medical EBITDA Margin %?

Epitomee Medical EPTMF 29 EBITDA Margin % is -1,770.89% as of Dec. 2025. GuruFocus rates EPTMF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Epitomee Medical ranks worse than 96.32% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Epitomee Medical's EBITDA for the six months ended in Dec. 2025 was $-3.77 Mil. Epitomee Medical's Revenue for the six months ended in Dec. 2025 was $0.21 Mil. Therefore, Epitomee Medical's EBITDA margin for the quarter that ended in Dec. 2025 was -1,770.89%.

Epitomee Medical  (OTCPK:EPTMF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Epitomee Medical EBITDA Margin % Related Terms

Epitomee Medical EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Epitomee Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epitomee Medical EBITDA Margin % Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 -49.86 0.00 -3,162.44

Epitomee Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.50 0.00 0.00 0.00 -1,770.89

EPTMF vs ABT, SYK, MDT: EBITDA Margin % Comparison

For the Medical Devices subindustry, Epitomee Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epitomee Medical EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Epitomee Medical's EBITDA Margin % falls into.


EPTMF
29GF Score
Epitomee Medical Ltd EPTMF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epitomee Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Epitomee Medical's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-6.736/0.213
=-3,162.44 %

Epitomee Medical's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-3.772/0.213
=-1,770.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -1,770.89% mean?
Epitomee Medical (EPTMF) has a EBITDA Margin % of -1,770.89% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Epitomee Medical and its competitors. According to the industry distribution chart, Epitomee Medical ranks #786 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 96.3%.
Is Epitomee Medical's EBITDA Margin % too high?
Epitomee Medical's current EBITDA Margin % is -1,770.89%. Based on the distribution chart, Epitomee Medical ranks #786 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Epitomee Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Epitomee Medical's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Epitomee Medical ranks #786 out of 816 companies for EBITDA Margin %. This places Epitomee Medical in the lower half of its industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Epitomee Medical and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epitomee Medical's current EBITDA Margin % is -1,770.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epitomee Medical stock overvalued right now?
Epitomee Medical (EPTMF) has a current EBITDA Margin % of -1,770.89%. The current EBITDA Margin % is -1,770.89%. Epitomee Medical's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Epitomee Medical (EPTMF), the current EBITDA Margin % is -1,770.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epitomee Medical Business Description

Other Exchanges EPIT:Israel
Address Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.
29GF Score

Get the complete analysis for EPTMF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.99
Price